Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2018 3
2019 2
2020 1
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
Martianov AS, Mitiushkina NV, Ershova AN, Martynenko DE, Bubnov MG, Amankwah P, Yanus GA, Aleksakhina SN, Tiurin VI, Venina AR, Anuskina AA, Gorgul YA, Shestakova AD, Maidin MA, Belyaev AM, Baboshkina LS, Iyevleva AG, Imyanitov EN. Martianov AS, et al. Among authors: venina ar. Int J Mol Sci. 2023 Mar 2;24(5):4868. doi: 10.3390/ijms24054868. Int J Mol Sci. 2023. PMID: 36902296 Free PMC article.
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas.
Tiurin VI, Preobrazhenskaya EV, Mitiushkina NV, Romanko AA, Anuskina AA, Mulkidjan RS, Saitova ES, Krivosheyeva EA, Kharitonova ED, Shevyakov MP, Tryakin IA, Aleksakhina SN, Venina AR, Sokolova TN, Martianov AS, Shestakova AD, Ivantsov AO, Iyevleva AG, Imyanitov EN. Tiurin VI, et al. Among authors: venina ar. Int J Mol Sci. 2023 Jun 23;24(13):10530. doi: 10.3390/ijms241310530. Int J Mol Sci. 2023. PMID: 37445709 Free PMC article.
Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer.
Sokolenko AP, Sultanova LV, Stepanov IA, Romanko AA, Venina AR, Sokolova TN, Musayeva HS, Tovgereeva MY, Magomedova MK, Akhmatkhanov KU, Vagapova EI, Suleymanov EA, Vasilyeva EV, Bakaeva EK, Bizin IV, Aleksakhina SN, Imyanitov EN. Sokolenko AP, et al. Among authors: venina ar. Cancer Med. 2023 Feb;12(3):3167-3171. doi: 10.1002/cam4.5159. Epub 2022 Aug 23. Cancer Med. 2023. PMID: 36000185 Free PMC article.
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.
Iyevleva AG, Aleksakhina SN, Sokolenko AP, Baskina SV, Venina AR, Anisimova EI, Bizin IV, Ivantsov AO, Belysheva YV, Chernyakova AP, Togo AV, Imyanitov EN. Iyevleva AG, et al. Among authors: venina ar. Breast Cancer Res Treat. 2022 Apr;192(2):283-291. doi: 10.1007/s10549-022-06517-3. Epub 2022 Jan 12. Breast Cancer Res Treat. 2022. PMID: 35020107
Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
Yanus GA, Akhapkina TA, Ivantsov AO, Preobrazhenskaya EV, Aleksakhina SN, Bizin IV, Sokolenko AP, Mitiushkina NV, Kuligina ES, Suspitsin EN, Venina AR, Holmatov MM, Zaitseva OA, Yatsuk OS, Pashkov DV, Belyaev AM, Togo AV, Imyanitov EN, Iyevleva AG. Yanus GA, et al. Among authors: venina ar. Clin Genet. 2018 May;93(5):1015-1021. doi: 10.1111/cge.13228. Epub 2018 Mar 9. Clin Genet. 2018. PMID: 29406563
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39.
Kuligina ES, Sokolenko AP, Bizin IV, Romanko AA, Zagorodnev KA, Anisimova MO, Krylova DD, Anisimova EI, Mantseva MA, Varma AK, Hasan SK, Ni VI, Koloskov AV, Suspitsin EN, Venina AR, Aleksakhina SN, Sokolova TN, Milanović AM, Schürmann P, Prokofyeva DS, Bermisheva MA, Khusnutdinova EK, Bogdanova N, Dörk T, Imyanitov EN. Kuligina ES, et al. Among authors: venina ar. Breast Cancer Res Treat. 2020 Feb;179(3):731-742. doi: 10.1007/s10549-019-05492-6. Epub 2019 Nov 21. Breast Cancer Res Treat. 2020. PMID: 31754952
BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study.
Frank GA, Aleksakhina SN, Zavalishina LE, Kekeyeva TV, Venina AR, Ivantsov AO, Mitiushkina NV, Moiseyenko AV, Pfeifer W, Strelkova TN, Imyanitov EN. Frank GA, et al. Among authors: venina ar. Melanoma Res. 2016 Oct;26(5):442-7. doi: 10.1097/CMR.0000000000000278. Melanoma Res. 2016. PMID: 27433783 No abstract available.
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
Moiseyenko VM, Moiseyenko FV, Yanus GA, Kuligina ES, Sokolenko AP, Bizin IV, Kudriavtsev AA, Aleksakhina SN, Volkov NM, Chubenko VA, Kozyreva KS, Kramchaninov MM, Zhuravlev AS, Shelekhova KV, Pashkov DV, Ivantsov AO, Venina AR, Sokolova TN, Preobrazhenskaya EV, Mitiushkina NV, Togo AV, Iyevleva AG, Imyanitov EN. Moiseyenko VM, et al. Among authors: venina ar. Clin Drug Investig. 2018 Jun;38(6):553-562. doi: 10.1007/s40261-018-0629-1. Clin Drug Investig. 2018. PMID: 29470838
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus.
Sokolenko AP, Bakaeva EK, Venina AR, Kuligina ES, Romanko AA, Aleksakhina SN, Belysheva YV, Belogubova EV, Stepanov IA, Zaitseva OA, Yatsuk OS, Togo AV, Khamgokov ZM, Kadyrova AO, Pirmagomedov AS, Bolieva MB, Epkhiev AA, Tsutsaev AK, Chakhieva MD, Khabrieva KM, Khabriev IM, Murachuev MA, Buttaeva BN, Baboshkina LS, Bayramkulova FI, Katchiev IR, Alieva LK, Raskin GA, Orlov SV, Khachmamuk ZK, Levonyan KR, Gichko DM, Kirtbaya DV, Degtyariov AM, Sultanova LV, Musayeva HS, Belyaev AM, Imyanitov EN. Sokolenko AP, et al. Among authors: venina ar. Breast Cancer Res Treat. 2024 Jan;203(2):307-315. doi: 10.1007/s10549-023-07135-3. Epub 2023 Oct 18. Breast Cancer Res Treat. 2024. PMID: 37851290
13 results